Menu
Back to User profile » Dr Sagar Munjal
Papers published by Dr Sagar Munjal:
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura
Lipton RB, Munjal S, Tepper SJ, Iaconangelo C, Serrano D
Journal of Pain Research 2021, 14:2529-2542
Published Date: 19 August 2021
Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial
Lipton RB, Munjal S, Dodick DW, Tepper SJ, Serrano D, Iaconangelo C
Journal of Pain Research 2021, 14:549-560
Published Date: 25 February 2021
Efficacy and safety of DFN-15, an oral liquid formulation of celecoxib, in adults with migraine: a multicenter, randomized, placebo-controlled, double-blind, crossover study
Munjal S, Bennett A
Neuropsychiatric Disease and Treatment 2017, 13:2797-2802
Published Date: 7 November 2017
Subcutaneous sumatriptan delivery devices: comparative ease of use and preference among migraineurs
Andre AD, Brand-Schieber E, Ramirez M, Munjal S, Kumar R
Patient Preference and Adherence 2017, 11:121-129
Published Date: 19 January 2017
The effect of weight, body mass index, age, sex , and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis
Munjal S, Gautam A, Rapoport AM, Fisher DM
Clinical Pharmacology: Advances and Applications 2016, 8:109-116
Published Date: 1 September 2016
Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients
Brand-Schieber E, Munjal S, Kumar R, Andre AD, Valladao W, Ramirez M
Medical Devices: Evidence and Research 2016, 9:131-137
Published Date: 30 May 2016